Organon divests JADA system to Laborie in $465m deal
Organon is selling its JADA post-partum haemorrhage (PPH) treatment system to Laborie Medical in a deal valued at up to …
Organon is selling its JADA post-partum haemorrhage (PPH) treatment system to Laborie Medical in a deal valued at up to …
Princess Margaret Cancer Centre, part of Canada's University Health Network (UHN), has partnered with genomics company Helix to undertake the …
Israel-based Nitinotes Surgical has gained a CE mark for EndoZip, enabling the company to launch the automated suturing platform for …
Artivion has treated the first subject in the multi-centre ARTIZEN pivotal study to assess the Arcevo LSA hybrid stent graft …
The growing burden of chronic kidney disease (CKD) and end-stage renal disease (ESRD) has been a major driver of demand …
US-based Synchron has secured $200m in a Series D funding round to drive the commercial rollout of its Stentrode brain-computer …
BillionToOne has become a newly minted public company, raising $273.1m in an upsized initial public offering (IPO), despite the longest …
Sovato has completed a Series B financing round to accelerate the development of its teleoperated robotic surgery system, which designed …
For nearly 25 years, Formacoat has made a name for itself in the coating application space. With an agnostic approach …
US-based robotics company Medical Microinstruments (MMI) has obtained an investigational device exemption (IDE) from the US Food and Drug Administration …
Registrar Corp has acquired CMC Medical Devices, a Spain-based company specialising in clinical, regulatory, and compliance services, for an undisclosed …
SPT Labtech and Swiss company Alithea Genomics have announced a partnership for automating single-cell transcriptomic workflows. The partnership combines the capabilities …
Brain-computer interface (BCI) company Precision Neuroscience has received an investment from SCI Ventures, a VC firm that claims to hold …
Over the past few decades, the pharmaceutical industry has seen a steady shift toward parenteral self-administration and home-based care. As …
Philips has maintained 2025 guidance after AI-powered innovation and sustained strength in the North American market powered Q3 comparable sales …